Τίτλος:
Hypogammaglobulinemia in rheumatoid arthritis patients treated with rituximab: should we switch biologics? Comment on the article by Fraenkel et al
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Evangelatos, G.
Moschopoulou, M.
Iliopoulos, A.
Fragoulis, G.E.
Περιοδικό:
Arthritis and Rheumatology
Εκδότης:
John Wiley and Sons Inc
Λέξεις-κλειδιά:
antibiotic agent; C reactive protein; disease modifying antirheumatic drug; immunoglobulin A; immunoglobulin G; immunoglobulin M; rituximab; antirheumatic agent; biological product; rituximab, antibiotic therapy; DAS28; disease activity; drug substitution; drug withdrawal; follow up; human; immunoglobulin blood level; immunoglobulin deficiency; immunotherapy; Letter; rheumatoid arthritis; risk factor; treatment switching; agammaglobulinemia, Agammaglobulinemia; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Humans; Rituximab
